Rose PG, Yao M, Chambers LM, Mahdi H, et al. PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer. Anticancer Drugs 2021 Sep 13. pii: 00001813-900000000-98269.
PMID: 34520432